Heart health measured with a simple blood test

February 8, 2018 by Nancy Bazilchuk, ScienceNordic
Credit: CC0 Public Domain

Researchers have discovered a new indicator that measures the risk of future heart disease. High levels of this substance, called troponin, can identify people at risk.

It's long been the holy grail of cardiac researchers: a simple blood test that can predict who is at greatest risk of developing disease. Cholesterol and C-reactive protein levels have long been used as proxies for this ideal indicator.

But two new studies document how individuals with heart disease had high levels of a protein, , in their blood long before they had symptoms, compared to individuals who did not have heart disease.

The studies also show that an increase of troponin over time indicates an increase in the risk of heart disease.

A sign of disease

Doctors have long tested the blood levels of troponin in people who come to a hospital with chest pain to determine if they are having a .

"This is a well-known marker for heart disease," says Magnus Nakrem Lyngbakken, a researcher at the University of Oslo (UiO) and Ahus, the Akershus University Hospital.

However, levels of this protein also vary in healthy people in the population.

Tested 9000 Norwegians

Researchers at UiO and Ahus relied on from several studies conducted by the Nord-Trøndelag Health Study. HUNT, as it is called after its Norwegian acronym, is one of the largest population-based health surveys ever conducted. The researchers used information from HUNT to look for early signs heart disease risk, using methods that are different than those used in hospital clinics today.

None of the participants had symptoms of heart disease when blood samples were collected during HUNT2, which was carried out from 1995-1997, and HUNT3, which was carried out from 2006-2008.

Frozen blood samples from over 9000 participants were thawed and tested for troponin.

Participants' blood samples were divided into three groups, based on whether they had low, moderate or high values of the protein.

330 died of heart disease

The researchers then compared these findings with records of hospitalizations and deaths until 2010. By that time, roughly 8 per cent of the participants had had a heart attack or .

Of the participants, 330 had died from heart disease, 270 had had a heart attack, and 135 had been hospitalized with heart failure.

Among these three groups, many more had high as early as 14 years previous to their diagnosed illness compared to individuals who did not develop heart disease.

None of the participants were known to have symptoms of heart disease when the blood tests were first taken.

The common denominator

Troponin appears to be a common denominator for various factors, such as and high cholesterol.

"It is a protein that is likely created by low grade heart failure. But we still do not know why people with heart disease have a higher levels of the protein many years before there is evidence of heart disease, compared to those without heart disease, "said Lyngbakken.

Better than measuring cholesterol

The researchers found that troponin levels are more likely to predict who is at risk of heart disease than more familiar measurements such as C-reactive protein.

Troponin also appears to be a better predictor of future heart disease than high levels of dangerous cholesterol, according to the study.

Nevertheless, age, diabetes and high pressure that require medical treatment are even stronger predictors of future heart disease than troponin levels.

Preventative treatment a goal

Currently, troponin levels can only be tested in hospitals.

But scientists hope that a test can be developed so your GP can determine who is most at risk of future heart disease.

"These people can then be offered preventive treatment," says Fjola Sigurdardottir, a Ph.D. candidate at UiO and Ahus whose dissertation focuses on troponin and .

Explore further: Troponin linked to increased risk of death

More information: Cardiac Troponin I Provides Superior Prognostic Information to C-Reactive Protein in the General Population: Data From The Nord-Trøndelag Health Study. Circulation. circ.ahajournals.org/content/1 … 343/tab-article-info

Temporal Changes in Cardiac Troponin I and Risk ofCardiovascular Events in the General Population: The Nord-Trøndelag Health Study. Circulation. circ.ahajournals.org/content/136/Suppl_1/A14527

Related Stories

Troponin linked to increased risk of death

November 3, 2017
A blood test that measures the presence of heart specific proteins called troponins is used by A&E hospitals to diagnose myocardial infarction in patients with chest pain. But even normal levels of the protein in patients ...

A simple blood test could help identify people at risk of a heart attack, a study has found

December 21, 2016
Research shows the troponin test – currently used to help diagnose a heart attack – could be used to assess future heart disease risk.

Heart test changes could save lives

April 25, 2017
New advice for doctors could prevent almost 3000 heart attacks being missed each year, Edinburgh researchers say. They have called for the guidelines on using blood tests to diagnose heart attacks to be urgently implemented ...

Higher risk of dying due to heart cell damage without any symptoms occurs during or after non-heart surgery

December 4, 2017
Surgery that doesn't involve the heart may cause damage to the heart in people with known or at high risk of developing heart disease and was associated with an increased risk of death, according to new research in the American ...

New blood test for diagnosing heart attacks: A 'big deal,' with caveats

January 16, 2018
When diagnosing a heart attack, accuracy and timing are everything.

New heart attack test could save NHS millions of pounds every year

September 29, 2017
A revolutionary new blood test for detecting a heart attack could speed up diagnosis and save the NHS millions of pounds every year, according to new research funded by the British Heart Foundation (BHF).

Recommended for you

To have or not to have... your left atrial appendage closed

May 22, 2018
Each year in the U.S., more than 300,000 people have heart surgery. To reduce risk of stroke for their patients, surgeons often will close the left atrial appendage, which is a small sac in the left side of the heart where ...

Natural antioxidant bilirubin may improve cardiovascular health

May 18, 2018
Bilirubin, a yellow-orange pigment, is formed after the breakdown of red blood cells and is eliminated by the liver. It's not only a sign of a bruise, it may provide cardiovascular benefits, according to a large-scale epidemiology ...

New algorithm more accurately predicts life expectancy after heart failure

May 17, 2018
A new algorithm developed by UCLA researchers more accurately predicts which people will survive heart failure, and for how long, whether or not they receive a heart transplant. The algorithm would allow doctors to make more ...

New genes found that determine how the heart responds to exercise

May 17, 2018
A new study by researchers at Queen Mary University of London and University College London (UCL) has discovered 30 new gene locations that determine how the heart responds to and recovers from exercise.

Novel therapy inhibits complement to preserve neurons and reduce inflammation after stroke

May 16, 2018
A team of investigators at the Medical University of South Carolina (MUSC) has developed a novel therapy for ischemic (clot-caused) stroke and has shown in a preclinical model that it locally inhibits complement at and around ...

Greater burden of atrial fibrillation linked to higher stroke risk

May 16, 2018
Among people with intermittently recurring atrial fibrillation who are not taking anti-blood-clotting medications, those whose hearts were in abnormal rhythms longer were three times more likely to have strokes or other types ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.